These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 77105)

  • 1. [The elimination of hydroxyethyl starch 200/0.5, dextran 40 and oxypolygelatine (author's transl)].
    Köhler H; Zschiedrich H; Linfante A; Appel F; Pitz H; Clasen R
    Klin Wochenschr; 1982 Mar; 60(6):293-301. PubMed ID: 6176754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacokinetic considerations in the use of plasma expanders.
    Klotz U; Kroemer H
    Clin Pharmacokinet; 1987 Feb; 12(2):123-35. PubMed ID: 2435442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elimination of hexamethylene diisocyanate cross-linked polypeptides in patients with normal or impaired renal function.
    Köhler H; Kirch W; Fuchs P; Stalder K; Distler A
    Eur J Clin Pharmacol; 1978 Dec; 14(6):405-12. PubMed ID: 738348
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetics of high molecular weight hydroxyethyl starch in dogs.
    Yacobi A; Gibson TP; McEntegart CM; Hulse JD
    Res Commun Chem Pathol Pharmacol; 1982 May; 36(2):199-204. PubMed ID: 6179136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on hydroxyethyl starch. Part II: Changes of the molecular weight distribution for hydroxyethyl starch types 450/0.7, 450/0.5, 450/0.3, 300/0.4, 200/0.7, 200/0.5, 200/0.3 and 200/0.1 after infusion in serum and urine of volunteers.
    Ferber HP; Nitsch E; Förster H
    Arzneimittelforschung; 1985; 35(3):615-22. PubMed ID: 2581591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Second effect on volume after a one-time infusion of hydroxyethyl starch].
    Köhler H; Kirch W; Pitz H
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1756-8. PubMed ID: 77106
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hyperamylasemia following infusion of hydroxyethyl starch with different molecular weight distributions].
    Gofferje H; Kozlik V
    Infusionsther Klin Ernahr; 1977 Jun; 4(3):141-4. PubMed ID: 70402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxyethyl starch. Control of alpha-amylase hydrolysis and its subsequent clinical application.
    Mishler JM
    Acta Haematol Pol; 1980; 11(2):113-6. PubMed ID: 6158825
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacokinetics of hydroxyethyl starch in kidney failure].
    Köhler H; Kirch W; Vogt J; Höffler D
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1676-8. PubMed ID: 77105
    [No Abstract]   [Full Text] [Related]  

  • 10. Hetastarch: an overview of the colloid and its metabolism.
    Hulse JD; Yacobi A
    Drug Intell Clin Pharm; 1983 May; 17(5):334-41. PubMed ID: 6190620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characteristics of the pharmacokinetics of drugs in renal failure].
    Nadzhimutdinov KN; Krakovskiĭ ME
    Farmakol Toksikol; 1985; 48(5):109-13. PubMed ID: 3908139
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hepatic clearance of drugs in kidney failure].
    Balant L
    Nephrologie; 1983; 4(2):45-7. PubMed ID: 6136004
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.